SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

HPV Vaccine Trials in India: Is Merck above the law?

By 14 Comments

Sanevax square

By Norma Erickson 3 July 2014: As a result of continued investigations regarding clinical trials involving HPV vaccines in India, more allegations of unethical conduct have been lodged against Merck. These allegations pertain to Merck’s recent trials of the new V503 HPV vaccine, a proposed nine valent HPV vaccine. A complete report of the investigation […]

[Continue reading...]

India: Are Pharmaceutical Companies Abusing Clinical Trial Participants?

By 1 Comment

[SaneVax: In India during 2010-11, there were 1106 people who died during clinical trials. Only 37 families were compensated for their loss. In 2010, clinical trials of Gardasil and Cervarix were halted after allegations of unethical conduct were raised by local consumer advocates and medical professionals. What is wrong with this picture?] Trial by error By […]

[Continue reading...]

PATH and HPV Vaccines in India: The clinical trials that should not have been

By 1 Comment

[SaneVax:  Why attempt to establish an HPV vaccination program where the epidemiological evidence does not support the need? Why attempt to establish a vaccination program where there is no adequate surveillance system in place to monitor efficacy? Why attempt to establish a vaccination program with the most expensive vaccine on the market in a country […]

[Continue reading...]

Question of Ethics

By Leave a Comment

By T.K. Rajalakshmi The effectiveness of the HPV vaccine in preventing cervical cancer was tested without proper consent from vulnerable subjects. EARLY last year, an ambitious, population-based, post-licensure study of the effectiveness of the human papillomavirus (HPV) vaccine to prevent cervical cancer conducted in selected districts of Andhra Pradesh and Gujarat by PATH, an international […]

[Continue reading...]

News

Videos

Contact